Skip to main content
  • DOACs Promising for Afib Patients With Mitral Stenosis

    Warfarin not necessarily the go-to therapy, Korean study finds

    Patients with mitral stenosis and atrial fibrillation (Afib) did well on direct oral anticoagulants (DOACs) for thromboembolic event prevention, retrospective data indicated.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details